2.35

2.62% 0.06

After Hours: 2.35

Cassava Sciences Inc (SAVA)

Overview News Price History Option Chain Financials Why SAVA Down? Discussions Forecast Stock Split Dividend History

Cassava Sciences Inc stock is traded at $2.35, with a volume of 3.17M. It is up +2.62% in the last 24 hours and down -90.98% over the past month. Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.

Previous Close:

$2.29

Open:

$2.24

24h Volume:

3.17M

Relative Volume:

0.64

Market Cap:

$113.06M

Revenue:

Net Income/Loss:

$-97.22M

P/E Ratio:

-1.0731

EPS:

-2.19

Net Cash Flow:

$-82.44M

1W Performance:

-14.55%

1M Performance:

-90.98%

6M Performance:

-88.24%

1Y Performance:

-91.53%

1-Day Range:

$2.23

$2.41

1-Week Range:

$2.23

$2.83

52-Week Range:

$2.23

$42.20

Cassava Sciences Inc Stock (SAVA) Company Profile

Name

Cassava Sciences Inc

Sector

Healthcare (1176)

Industry

Biotechnology (673)

Phone

512-501-2444

Address

6801 N CAPITAL OF TEXAS HIGHWAY, AUSTIN, TX

Employee

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

SAVA's Discussions on Twitter

Compare SAVA with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SAVA Cassava Sciences Inc	2.35	113.06M	0	-97.22M	-82.44M	-2.32
VRTX Vertex Pharmaceuticals Inc	397.27	102.31B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	701.85	77.13B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	623.82	37.30B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	245.44	31.66B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	113.08	27.11B	3.30B	-501.07M	1.03B	-2.1146

Cassava Sciences Inc Stock (SAVA) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-26-24	Downgrade	H.C. Wainwright	Buy → Neutral
Oct-08-24	Upgrade	H.C. Wainwright	Neutral → Buy
Jul-01-24	Downgrade	H.C. Wainwright	Buy → Neutral
Nov-16-22	Downgrade	B. Riley Securities	Buy → Neutral
Jul-15-21	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Jul-07-21	Reiterated	Maxim Group	Buy
Apr-27-21	Initiated	B. Riley Securities	Buy
Feb-16-21	Reiterated	H.C. Wainwright	Buy
Oct-23-20	Initiated	Cantor Fitzgerald	Overweight
Sep-23-20	Upgrade	H.C. Wainwright	Neutral → Buy
May-18-20	Downgrade	H.C. Wainwright	Buy → Neutral
May-15-20	Downgrade	Maxim Group	Buy → Hold
Jan-10-20	Reiterated	Maxim Group	Buy

View All

Cassava Sciences Inc Stock (SAVA) Latest News

Dec 20, 2024

CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassav - The Malaysian Reserve

Dec 20, 2024

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Cassava Sciences, Inc. of Class Action Lawsuit and Upcoming DeadlinesSAVA - PR Newswire

Dec 20, 2024

SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - GlobeNewswire Inc.

Dec 20, 2024

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Cassava - GlobeNewswire

Dec 20, 2024

Class Action Filed Against Cassava Sciences, Inc. (SAVA)February 10, 2025 Deadline to JoinContact The Gross Law Firm - Longview News-Journal

Dec 20, 2024

Dec 19, 2024

Levi & Korsinsky Reminds Cassava Sciences, Inc. Investors - GlobeNewswire

Dec 19, 2024

SAVA Stock Plummets to 52-Week Low at $2.33 Amid Market Challenges - Investing.com

Dec 19, 2024

Dec 18, 2024

SAVA Investors Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit - The Malaysian Reserve

Dec 18, 2024

SAVA STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Dec 18, 2024

SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - Business Wire

Dec 18, 2024

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cassava - PR Newswire

Dec 18, 2024

CASSAVA SCIENCES, INC. (NASDAQ: SAVA) INVESTOR ALERT: - GlobeNewswire

Dec 18, 2024

Dec 17, 2024

CASSAVA SCIENCES SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Cassava Sciences, Inc. - GlobeNewswire Inc.

Dec 17, 2024

CASSAVA ALERT: Bragar Eagel & Squire, P.C. Announces that a - GlobeNewswire

Dec 17, 2024

ROSEN, A LONGSTANDING LAW FIRM, Encourages Cassava - GlobeNewswire

Dec 17, 2024

SAVA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Dec 17, 2024

Levi & Korsinsky Notifies Cassava Sciences, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineSAVA - Longview News-Journal

Dec 17, 2024

Dec 16, 2024

Investor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Cassava Sciences, Inc. - PR Newswire

Dec 16, 2024

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Cassava Sciences, Inc. - EIN News

Dec 16, 2024

Cassava Sciences, Inc. Sued for Securities Law Violations – - GlobeNewswire

Dec 16, 2024

The Manufacturers Life Insurance Company Sells 7,458 Shares of Cassava Sciences, Inc. (NASDAQ:SAVA) - Defense World

Dec 16, 2024

Cassava Sciences, Inc. (NASDAQ:SAVA) Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - Defense World

Dec 16, 2024

Dec 15, 2024

SAVA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Dec 15, 2024

Dec 14, 2024

ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Cassava - GlobeNewswire

Dec 14, 2024

Dec 13, 2024

SAVA Investors with Losses in Excess of $100K Have Opportunity to Lead Cassava Sciences, Inc. Securities Fraud Lawsuit - The Malaysian Reserve

Dec 13, 2024

SAVA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Dec 13, 2024

Rosen Law Firm Urges Cassava Sciences, Inc. (NASDAQ: SAVA) Stockholders with Large Losses in Excess of $100K to Contact the Firm for Information About Their Rights - The Bakersfield Californian

Dec 13, 2024

SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of - GlobeNewswire

Dec 13, 2024

SAVA SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Cassava Sciences, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - AccessWire

Dec 13, 2024

375,000 Shares in Cassava Sciences, Inc. (NASDAQ:SAVA) Bought by Tidal Investments LLC - MarketBeat

Dec 13, 2024

Dec 12, 2024

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors - GlobeNewswire

Dec 12, 2024

Lost Money on Cassava Sciences, Inc.(SAVA)? Join Class Action Suit Seeking Recovery – Contact Levi & Korsinsky LLP - TipRanks

Dec 12, 2024

Cassava Shares Sink as CEO Resigns From Troubled Biotech Company - MSN

Dec 12, 2024

SAVA Stock Plummets to 52-Week Low at $2.77 Amid Market Challenges By Investing.com - Investing.com South Africa

Dec 12, 2024

Dec 11, 2024

SAVA Stock Plummets to 52-Week Low at $2.77 Amid Market Challenges - Investing.com India

Dec 11, 2024

RIP simufilam, we hardly knew ye - Healthcare Brew

Dec 11, 2024

Dec 09, 2024

Bronstein, Gewirtz & Grossman, LLC Is Investigating Cassava Sciences, Inc. (SAVA) And Encourages Shareholders to Connect - AccessWire

Dec 09, 2024

Dec 08, 2024

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Cassava Sciences, Inc. (SAVA) And Encourages Shareholders to Reach Out - AccessWire

Dec 08, 2024

Dec 06, 2024

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Cassava Sciences, Inc. (SAVA) and Encourages Shareholders to Learn More About the Investigation - AccessWire

Dec 06, 2024

Dec 05, 2024

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Cassava Sciences, Inc. (SAVA) and Encourages Investors to Learn More About the Investigation - AccessWire

Dec 05, 2024

Dec 04, 2024